Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deborah J. Wexler MD, MSc Associate Editor

Kathleen M. Dungan MD, MPH Advisory Board

Silvio E. Inzucchi MD Editor-in-Chief

See All Experts

featured

Published in Diabetes and

Expert Opinion / Interview · March 26, 2018

Rationale and Contemporary Options for High-Intensity Cholesterol Treatment: Statins

Interview by

Jennifer N. Caudle DO

Interview with

Peter Libby MD

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

Disclosures

Disclosure statements are available on the authors' profiles:

Peter Libby MD

featured

Impact of GLP-1 Receptor Agonist–Based Treatments on Fat-Free Mass

Diabetes Obes Metab · October 30, 2024
featured

Effects of GLP-1 Receptor Agonists Used as an Adjunct to Insulin Therapy on HbA1c Levels and CGM Metrics in Adults With Type 1 Diabetes

Diabetes Obes Metab · October 29, 2024
story of the week

Technology in Managing Diabetes in Hospitalised Adults

Diabetologia · October 29, 2024
featured

Diabetes Technology in People With Diabetes and Advanced Chronic Kidney Disease

Diabetologia · October 28, 2024
featured

Estimating the Risk of Consequences Following Hypoglycaemia Exposure

Diabetologia · October 27, 2024

updated
story of the week

Implications of Continuous Ketone Monitoring in Clinical Practice

Diabetes Obes Metab · October 25, 2024

updated
featured

Impact of Automated Insulin Delivery System Use on Glycemic Control in Children and Adolescents With Type 1 Diabetes

Diabetes Obes Metab · October 24, 2024
featured

Replication of the European Subtypes of Type 2 Diabetes in a Chinese Population

Diabetes Res. Clin. Pract. · October 24, 2024
featured

Clinical Practice Guidelines for Managing Pregnancy Following Metabolic Bariatric Surgery

Obesity · October 23, 2024
featured

CGM-Based Metrics and Duration of Hypoglycaemic Events With Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 in Insulin-Naive Type 2 Diabetes

Lancet Diabetes Endocrinol · October 23, 2024
featured

Higher Fibre and Lower Carbohydrate Intake Are Associated With Favourable CGM Metrics in Type 1 Diabetes

Diabetologia · October 22, 2024

updated

Obesity, Metabolic Syndrome, and Prediabetes

Rationale and Contemporary Options for High-Intensity Cholesterol Treatment: Statins

Additional Info

Further Reading

Impact of GLP-1 Receptor Agonist–Based Treatments on Fat-Free Mass

Effects of GLP-1 Receptor Agonists Used as an Adjunct to Insulin Therapy on HbA1c Levels and CGM Metrics in Adults With Type 1 Diabetes

Technology in Managing Diabetes in Hospitalised Adults

Diabetes Technology in People With Diabetes and Advanced Chronic Kidney Disease

Estimating the Risk of Consequences Following Hypoglycaemia Exposure

Implications of Continuous Ketone Monitoring in Clinical Practice

Impact of Automated Insulin Delivery System Use on Glycemic Control in Children and Adolescents With Type 1 Diabetes

Replication of the European Subtypes of Type 2 Diabetes in a Chinese Population

Clinical Practice Guidelines for Managing Pregnancy Following Metabolic Bariatric Surgery

CGM-Based Metrics and Duration of Hypoglycaemic Events With Once-Weekly Insulin Icodec vs Once-Daily Insulin Glargine U100 in Insulin-Naive Type 2 Diabetes

Higher Fibre and Lower Carbohydrate Intake Are Associated With Favourable CGM Metrics in Type 1 Diabetes

Related Videos